Abstract Session
Hematologic- and oncologic-associated rheumatic syndromes
Laura Cappelli, MD
Johns Hopkins School of Medicine
Baltimore, MD, United States
Disclosure(s): Bristol-Myers Squibb(BMS): Consultant (Ongoing), Grant/Research Support (Ongoing); Mallinckrodt: Advisor or Review Panel Member (Terminated, November 15, 2021); Tremeau Pharmaceuticals: Consultant (Terminated, May 10, 2022)